SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001654954-18-010337
Filing Date
2018-09-20
Accepted
2018-09-20 17:24:35
Documents
15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT f-1.htm F-1 1385469
2 INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES INSTRU ex425.htm EX-4.25 104350
3 OPINION ON LEGALITY ex51.htm EX-5.1 30276
4 OPINION ON LEGALITY ex52.htm EX-5.2 15858
5 CONSENTS OF EXPERTS AND COUNSEL ex231.htm EX-23.1 4827
6 CONSENTS OF EXPERTS AND COUNSEL ex232.htm EX-23.2 7157
7 IMAGE deloitte_logo.jpg GRAPHIC 2439
8 IMAGE ex52000.jpg GRAPHIC 1557
9 IMAGE gowlings1.jpg GRAPHIC 7034
10 IMAGE gowlings2.jpg GRAPHIC 7034
11 IMAGE gowlings3.jpg GRAPHIC 7034
12 IMAGE intellipharmaceutics_logo.jpg GRAPHIC 7239
13 IMAGE mnp_address-1.jpg GRAPHIC 5048
14 IMAGE mnp_address-2.jpg GRAPHIC 6286
15 IMAGE mnp_logo.jpg GRAPHIC 2454
  Complete submission text file 0001654954-18-010337.txt   1613803
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: F-1 | Act: 33 | File No.: 333-227448 | Film No.: 181080107
SIC: 2834 Pharmaceutical Preparations